The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • Department of Defense funds $8 million grant for Long COVID trials

    Department of Defense funds $8 million grant for Long COVID trials

    Betsy Ladyzhets

    A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant. Read more…

Recent articles

  • National COVID-19 trends, September 1
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, September 1

  • Research updates, September 1
    Science
    Miles W. Griffis

    Research updates, September 1

  • “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID
    Commentary
    Kelly Sealey

    “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Department of Defense funds $8 million grant for Long COVID trialsDepartment of Defense funds $8 million grant for Long COVID trialsBetsy Ladyzhets
Long Covid advocates face challenges, potential discrimination with billboard campaignsLong Covid advocates face challenges, potential discrimination with billboard campaignsSimon Spichak
National COVID-19 trends, September 1National COVID-19 trends, September 1Betsy Ladyzhets
Research updates, September 1Research updates, September 1Miles W. Griffis
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis

Policy & Advocacy

Science

  • nurse wiping the arm of a patient
    April 16, 2024

    Research updates, April 16

  • April 9, 2024

    Hidden disability: The quiet struggle with Long Covid in Kenya

  • red and blue industrial exhaust fans
    April 9, 2024

    Research updates, April 9

  • April 2, 2024

    How patient-led research could speed up medical innovation

  • set of medical equipment for taking analysis from vein
    April 2, 2024

    Research updates, April 2

  • March 26, 2024

    Want to enroll in a Long Covid clinical trial? This new project helps track them.

Previous Page
1 … 31 32 33 34 35 … 38
Next Page

Covid-19

Health

Commentary

  • September 30, 2025

    Patricia Lockwood explores the depths of Long COVID in the new novel “Will There Ever Be Another You”

  • September 23, 2025

    Letter to the editors: Concerns about California’s right-to-mask bill

  • September 12, 2025

    Stop looking for a silver bullet. Start mixing the Long COVID cocktail.

  • A graphic showing white KN94 masks and yellow and white megaphones in a neat pattern that alternates the two objects. The background is a dark navy.
    September 2, 2025

    How do you get people to care about COVID-19? Here’s what I’ve learned as an organizer.

Previous Page
1 … 8 9 10 11 12 … 27
Next Page

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...